期刊文献+

全肠外营养相关肝损害小鼠模型的建立 被引量:2

Parenteral nutrition induces liver disease in a mouse model
下载PDF
导出
摘要 目的:为进一步研究肠外营养(PN)相关肝损害(PNALD)的患病机制及干预措施,建立有效的小鼠模型。方法:将20只小鼠随机分为对照组和模型组,对照组小鼠正常饮食、颈静脉置管后微量泵持续输注等渗盐水;模型组小鼠禁食后颈静脉置管,用微量泵持续输注PN液。1周后比较两组小鼠体重变化,血清生化指标以及肝组织学改变。结果:模型组小鼠体重明显低于对照组(P<0.05),直接胆红素、总胆红素和胆固醇均显著高于对照组(P<0.05),且肝组织在光镜下可见广泛性肝细胞脂肪变性,细胞质内出现大小不一的空泡,主要集中于中央静脉周围。脂肪变性评分为(3.1±0.5)分,显著高于对照组(1.0±0.0)分。结论:模型组小鼠与成人PNALD病人初期的临床和病理改变相似,可用于该病的患病机制,药物治疗疗效以及具体机制的观察和研究。 Objectives: This study was to ed liver disease. Methods: C57BL/6J female develop a mouse model of parenteral nutrition-associat- mice (aged 6 -8 weeks) were randomly assigned to parenteral nutrition or control group. A central venous catheter was inserted for intravenous infusion of a parenteral nutrition solution (model group ) or saline (control group ) for 7 days. Weights changes, hepatic biochemical tests and liver pathology were analyzed. Results: The model group gained signifi- cantly less weight than the control group (P 〈 0.05 ). The model group showed significant increases in direct bilirubin, total bilirubin and serum cholesterol to the control group ( P 〈 0.05 ). Livers in model group had severe, diffuse involvement of hepatocytes by macrovesicular and microvesicular steatosis. The pathological score were significantly higher in the model group than the control group ( 3.1 ± 0.5 and 1.0 ± 0.0 respectively, P 〈 0. 05 ). Conclusion : The model provides the opportunity to further investi-gate pathogenesis and treatment of parenteral nutrition-associated liver disease.
出处 《肠外与肠内营养》 CAS 北大核心 2013年第4期231-234,共4页 Parenteral & Enteral Nutrition
基金 国家自然科学基金资助(81270945)
关键词 全肠外营养 肠外营养相关肝损害 胆汁淤积 Total parenteral nutrition Parenteral nutrition associated liver disease Cholestasis
  • 相关文献

参考文献4

二级参考文献32

  • 1Hood L,Heath JR,Phelps ME,et al. Systems biology, and new technologies enable predictive and preventative medicine. Science,2004,306(5696 ) :640-643.
  • 2Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med,2010,2(8) :57-60.
  • 3Zeisel SH. Nutrigenomics and metabolomics will change clinical nutrition and public health practice:insights from studies on dietary requirements for choline. Am J Clin Nutr,2007,86 (3) :542- 548.
  • 4Go VL, Nguyen CT, Harris DM, Lee WN. Nutrient-gene interaction: metabolic genotype-phenotype relationship. J Nutr,2005, 135 ( 12 Suppl) :3016S-3020S.
  • 5Steiner C,Arnould S, Scalbert A, et al. soflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr,2008,99( Suppl 1 ) : ES78-108.
  • 6Loktionov A,Scollen S, McKeown N, et al. Gene-nutrient interactions :dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals. Br J Nutr,2000, 84(6) :885-890.
  • 7Kussmann M, Krause L, Siffert W. Nutrigenomics: where are we with genetic and epigenetic markers for disposition and susceptibility? Nutr Rev,2010,68(Suppl 1 ) :S38-47.
  • 8Subbiah MT. Nutrigenetics and nutraceuticals:the next wave riding on personalized medicine. Transl Res,2007,149 (2) :55-61.
  • 9Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition, 1991,7 (1) : 1-5, discussion 5-6.
  • 10Kelly DA. Intestinal failure-associated liver disease:what do we know today .9 Gastroenterology,2006,130 ( 2 Suppl 1 ) : $70 -77.

共引文献40

同被引文献21

  • 1梁冰,王斯闻.左卡尼汀在全肠外营养大鼠短肠综合征模型中的作用[J].中国老年学杂志,2014,34(5):1332-1333. 被引量:2
  • 2危重病人营养支持指导意见(2006)[J].中国实用外科杂志,2006,26(10):721-732. 被引量:174
  • 3彭南海,高勇.临床营养护理指南--肠内营养部分[M].南京:东南大学出版社,2012:6.
  • 4中华医学会.临床诊疗指南-肠外肠内营养学分册[M].北京:人民卫生出版社,2008:16-18.
  • 5Plauth M,Cabre E,Campillo B ,et al. ESPEN guidelines on parenteral nutrition:hepatology [J]. Clinical Nutrition, 2009, 28(4) :436-444.
  • 6Sahay M, Sahay R, Kalra S, et al. Nutrition in chronic kid- ney disease [J]. Journal of Medical Nutrition and Nutraceu- ticals,2014,3 (1) : 11.
  • 7蔡威译.临床营养基础[M].4版.上海:上海交通大学出版社,2010:333.
  • 8Naini BV, Lassman CR. Total parenteral nutrition therapy and liv- er injury:a histopathologie study with clinical correlation[ J ]. Hu- man pathology ,2012,43 ( 6 ) :826 - 833.
  • 9Tillman EM. Review and clinical update on parenteral nutrition-as- sociated liver disease [ J ]. Nutrition in Clinical Practice, 2013,28 (1) :30 -39.
  • 10Gude D. Throwing light on parenteral nutrition-associated liver disease [ J]. Journal of Medical Nutrition and Nutraceuticals,2013,2(2) :113.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部